Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon- as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
Annals of Oncology, 06/24/09
Castellano D et al. - Results consistently showed that patients in sunitinib group experienced statistically significantly milder kidney-related symptoms, better cancer-specific HRQoL and general health status (in social utility scores) during the study period as measured by these patient-reported outcome end points. No statistical differences between groups were found on the FACT-G physical well-being subscale or the EQ-5D VAS values.
Related Articles
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 83%
Prognostic Value of Capsular Invasion for Localized Clear-Cell Renal Cell Carcinoma
European Urology, 11/10/09
Relevance Score: 83%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 83%
Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey
European Journal of Cancer Care, 10/22/09
Relevance Score: 83%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 83%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management for Patients with De Novo or Recurrent Tumors in the Residual Kidney after Surgery for Nonfamilial Bilateral Renal Cell Carcinoma
Advances in Urology, 12/01/09
Tacrolimus enhances transforming growth factor-[beta]1 expression and promotes tumor progression
Transplantation, 12/01/09
The Motion: Cryotherapy is an Efficient Alternative for Kidney Cancer
European Urology, 11/30/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Nebivolol Improves Renal Function in Patients Who Underwent Angioplasty due to Renal Artery Stenosis: A Pilot Study
Nephron: Clinical Practice, 12/01/09
Rasburicase improves hyperuricemia in infants with acute kidney injury
Pediatric Nephrology, 12/01/09
Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome
Pediatric Nephrology, 12/01/09
Article Search
Sponsor


See Latest Articles


